MET and pancreatic ductal adenocarcinoma: In contrast, the c-Met-targeting strategy explored here, using CAR macrophages that directly target pancreatic ductal adenocarcinoma cells with high c-Met expression, exhibits high specificity and substantial tumor-suppressive effects.